Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
02/11/1998 | EP0822807A2 Gel with increased oxygen content |
02/11/1998 | EP0822758A1 Supplement for baby infant formula and a method of delivering that supplement |
02/11/1998 | EP0714407B1 Composition and methods using nitroxides to avoid oxygen toxicity |
02/11/1998 | EP0688429B1 Macromolecular microparticles and methods of production |
02/11/1998 | EP0630263B1 Pharmaceutical composition having site-specific delivery |
02/11/1998 | EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
02/11/1998 | CN1173134A Use of incense in the treatment of alzheimer's disease |
02/11/1998 | CN1173129A Anti-inflammatory eyecrops |
02/11/1998 | CN1173128A Polynucleotide compositions |
02/11/1998 | CN1172677A Fill material for soft gelatin pharmaceutical dosage form |
02/11/1998 | CN1172652A External use cream for treating skin disease |
02/11/1998 | CN1172650A Medicine for guiding cancer cell differentiation and its use on treating and prevent cancer |
02/11/1998 | CN1172646A Fill material for soft gelatin pharmaceutical dosage form containing antiflatulent |
02/11/1998 | CN1172643A Preparation of salts of pharmaceutical active substances which have acidic groups |
02/11/1998 | CN1172642A Multiphase soft gelatin dosage form |
02/11/1998 | CN1037318C Airosol generating composition of smoke product base material, smoke base material and cigarette |
02/10/1998 | US5717087 For molded parts, sheets, fibers, coatings, blends, laminates, matrices for delayed release of active materials, paper coatings |
02/10/1998 | US5717030 Adjunctive polymer system for use with medical device |
02/10/1998 | US5716991 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
02/10/1998 | US5716988 Ready-to-use; parenteral administering |
02/10/1998 | US5716987 Topically or transdermally administering phenoxyacetic acid and/or its lower alkyl ester |
02/10/1998 | US5716981 A stent coated with paclitaxel, a taxan derivative and a polymeric carrier; medical equipment for deblocking |
02/10/1998 | US5716978 Methods of treating circadian rhythm disorders |
02/10/1998 | US5716935 Applying polypeptide in carrier to wound to accelerate healing |
02/10/1998 | US5716931 Administering lantibiotic by aerosol |
02/10/1998 | US5716838 Culture of microorganisms such as rhizobium, arthrobacter |
02/10/1998 | US5716648 Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel diseases |
02/10/1998 | US5716644 Lyophilized solution containing erythropoietin, ammonium sulfate, ph 5-7 buffer |
02/10/1998 | US5716643 Large scale production of medicine coated crosslinked protein microspheres |
02/10/1998 | US5716642 Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents |
02/10/1998 | US5716641 Simethicone containing pharmaceutical compositions |
02/10/1998 | US5716640 Water in oil emulsion |
02/10/1998 | US5716639 A grain extract glycolipids; drugs, cosmetics, foods, nutrients; biocompatibility |
02/10/1998 | US5716638 Using liposomes |
02/10/1998 | US5716637 Solid fat nanoemulsions as vaccine delivery vehicles |
02/10/1998 | US5716636 Transdermal therapeutic system with acetylsalicylic acid in crystalline form as active substance |
02/10/1998 | US5716635 Plantago major transdermal patch for use in treating a tobacco or nicotine habit |
02/10/1998 | US5716634 Clear, homogenized, flowable hydrogel of crosslinked N-vinyl lactam polymer |
02/10/1998 | US5716632 Administering n-substituted 2-(1h)pyridones or 3-(1h)pyridones |
02/10/1998 | US5716631 Solubilized within polymer matrix |
02/10/1998 | US5716626 Skin cleanser |
02/10/1998 | US5716621 Nonocclusive drug delivery device and process for its manufacture |
02/10/1998 | US5716611 Topical formulation including water soluble emollient comprising ethoxylated higher aliphatic alcohol and ethoxylated cholesterol derivative |
02/10/1998 | US5716610 A mixture of water soluble vinyl polymer gel, amine alcohol dispersant, water and histamine phosphate is used topically to treat herpes labialis and/genitalis, chicken pox, heat and sun burn, aphthous stomatitis, allergic conjunctivitis |
02/10/1998 | US5716609 Therapeutic anti-inflammatory and analgesic composition containing nimesulide for use transdermally and a process for the manufacture thereof |
02/10/1998 | US5716597 A site-specific liquid-liquid emulsion useful as imaging agent for ultrasonic imaging of animal, consists of water, water insoluble gas forming perfluorohydrocarbon, a stabilizer either hdrophobic or hydrophilic compound |
02/10/1998 | US5716526 Filtration through filter of ceramic substrate and membrane, both having controlled porosity |
02/10/1998 | US5715824 Biological apparatus comprising a vessel for foaming procedure |
02/10/1998 | CA2069760C Lipid formulation system |
02/10/1998 | CA2003529C Film-enrobed, unitary-core medicament and the like |
02/09/1998 | CA2184799A1 Nifedipine containing pharmaceutical extended release composition and a process for the preparation thereof |
02/05/1998 | WO1998004394A1 A process to manufacture sustained release medicaments |
02/05/1998 | WO1998004341A1 Solubilizers, emulsifiers and dispersants |
02/05/1998 | WO1998004279A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
02/05/1998 | WO1998004258A1 Formulation for the treatment and/or prophylaxis of dementia |
02/05/1998 | WO1998004249A2 Tramadol multiple unit formulations |
02/05/1998 | WO1998004248A1 Dietary supplements |
02/05/1998 | WO1998004244A1 Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms |
02/05/1998 | WO1998004243A1 Preparation of colored powders/granulates by means of a fluid bed drying apparatus |
02/05/1998 | WO1998004242A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
02/05/1998 | WO1998004220A1 Intravaginal rings with insertable drug-containing core |
02/05/1998 | WO1998004136A1 Film-building agent useful to protect against infections |
02/05/1998 | WO1997049736A3 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
02/05/1998 | WO1997048384A3 Marking rapidly disintegrating dosage forms |
02/05/1998 | WO1997048369A3 Prophylactic and therapeutic treatment of skin sensitization and irritation |
02/05/1998 | WO1997038663A3 Buccal, non-polar spray or capsule |
02/05/1998 | WO1997038010A3 Fusogenic liposomes |
02/05/1998 | DE19707081A1 Filmbildendes Mittel zum Schutz vor Infektionen Film-forming agent to protect against infection |
02/05/1998 | DE19631189A1 Neuartige kationische Amphiphile für den liposomalen Gentransfer Novel cationic amphiphiles for the liposomal gene transfer |
02/05/1998 | DE19631084A1 Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut Use of (meth) acrylic acid copolymers to increase the permeability of the mucosal |
02/05/1998 | DE19630954A1 Product coating |
02/05/1998 | CA2263460A1 Use of cyanoacrylate adhesives for providing a protective barrier film for the skin |
02/05/1998 | CA2261949A1 Film-building agent useful to protect against infections |
02/05/1998 | CA2261764A1 Dietary supplements |
02/05/1998 | CA2261718A1 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
02/05/1998 | CA2261233A1 Formulation for the treatment and/or prophylaxis of dementia |
02/04/1998 | EP0822217A1 Heterotelechelic block copolymers and process for producing the same |
02/04/1998 | EP0821965A2 Use of copolymers of (meth)accrylic and maleic acid for the manufacture of a medicament for enhancing the permeability of the mucose |
02/04/1998 | EP0821959A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine for treating nicotine withdrawal |
02/04/1998 | EP0821958A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating excessive aggression |
02/04/1998 | EP0821956A1 Method for treating disruptive behavior disorders |
02/04/1998 | EP0821955A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating bipolar disorder |
02/04/1998 | EP0821951A1 Process for preparing a bicarbonate-containing infusion- or dialysis solution |
02/04/1998 | EP0821950A2 Clear hydroalcoholic solution of multivitamins containing physiologically active quantity of beta-carotene |
02/04/1998 | EP0821584A1 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection |
02/04/1998 | EP0821583A1 Dna vaccines against rotavirus infections |
02/04/1998 | EP0821582A2 Controlled release tablet |
02/04/1998 | EP0730494B1 Particles for binding monovalent cations and their use |
02/04/1998 | EP0655916B1 Transdermal application agent containing 3-keto-desogestrel |
02/04/1998 | CN1172434A Use of angiotensin II fragments and analogs thereof in tissue repair |
02/04/1998 | CN1172433A Sucralfate preparation |
02/04/1998 | CN1172431A Use of melatonin for treating patients suffering from drug addiction |
02/04/1998 | CN1172430A Plaster containing estradiol |
02/04/1998 | CN1172429A Sustained-release drug delivery employing powdered hydrocolloid gum obtainable from higher plants |
02/04/1998 | CN1172428A Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and speed of dissolution |
02/04/1998 | CN1171966A Health-care tea for preventing angiocardiopathy or cerebrovascular diseases and its preparing method |
02/04/1998 | CN1171960A Compound sophora flavescens injection |
02/04/1998 | CN1171956A Luxian oral liquor and its preparation method |
02/04/1998 | CN1171946A Shanqisan powder for curing hernia and its preparing method |
02/04/1998 | CN1171936A Traditional Chinese medicine plaster and its preparation method |